Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Melanoma treatment details. Chemotherapy. INSERM, Paris, France



Survival: 10.8 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: France
   
City/State/Province: Paris
   
Hospital: INSERM
   
Journal: Link
   
Date: 1/2015

Description:
Patients:
This phase 3 study involved 208 advanced metastatic melanoma patients. The median patient age was 66 years and 60.1% were male.

Treatment:
Patients received chemotherapy with dacarbazine.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 neutropenia, thrombocytopenia, and fatigue. Nausea, diarrhea, and constipation were also reported.

Results:
The median overall survival was 10.8 months.

Support:
This study was supported by Bristol-Myers Squibb.

Correspondence: Dr. Caroline Robert; email: caroline.robert@gustaveroussy.fr

E-mail to a Friend Email Physician More Information